Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2010 1
2012 2
2013 1
2014 2
2015 1
2016 2
2017 5
2018 2
2019 10
2020 3
2021 7
2022 9
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial.
Sands BE, Irving PM, Hoops T, Izanec JL, Gao LL, Gasink C, Greenspan A, Allez M, Danese S, Hanauer SB, Jairath V, Kuehbacher T, Lewis JD, Loftus EV Jr, Mihaly E, Panaccione R, Scherl E, Shchukina OB, Sandborn WJ; SEAVUE Study Group. Sands BE, et al. Lancet. 2022 Jun 11;399(10342):2200-2211. doi: 10.1016/S0140-6736(22)00688-2. Lancet. 2022. PMID: 35691323 Clinical Trial.
Guselkumab for the Treatment of Crohn's Disease: Induction Results From the Phase 2 GALAXI-1 Study.
Sandborn WJ, D'Haens GR, Reinisch W, Panés J, Chan D, Gonzalez S, Weisel K, Germinaro M, Frustaci ME, Yang Z, Adedokun OJ, Han C, Panaccione R, Hisamatsu T, Danese S, Rubin DT, Sands BE, Afzali A, Andrews JM, Feagan BG; GALAXI-1 Investigators. Sandborn WJ, et al. Among authors: afzali a. Gastroenterology. 2022 May;162(6):1650-1664.e8. doi: 10.1053/j.gastro.2022.01.047. Epub 2022 Feb 5. Gastroenterology. 2022. PMID: 35134323 Free article. Clinical Trial.
Immune-Mediated Colitis.
Menon T, Afzali A. Menon T, et al. Among authors: afzali a. Curr Treat Options Gastroenterol. 2019 Dec;17(4):506-523. doi: 10.1007/s11938-019-00263-0. Curr Treat Options Gastroenterol. 2019. PMID: 31741212 Review.
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium.
Johnson AM, Barsky M, Ahmed W, Zullow S, Galati J, Jairath V, Narula N, Peerani F, Click BH, Coburn ES, Dang TT, Gold S, Agrawal M, Garg R, Aggarwal M, Mohammad D, Halloran B, Kochhar GS, Todorowski H, Ud Din NM, Izanec J, Teeple A, Gasink C, Muser E, Ding Z, Swaminath A, Lakhani K, Hogan D, Datta S, Ungaro RC, Boland BS, Bohm M, Fischer M, Sagi S, Afzali A, Ullman T, Lawlor G, Baumgart DC, Chang S, Hudesman D, Lukin D, Scherl EJ, Colombel JF, Sands BE, Siegel CA, Regueiro M, Sandborn WJ, Bruining D, Kane S, Loftus EV Jr, Dulai PS. Johnson AM, et al. Among authors: afzali a. Am J Gastroenterol. 2023 Feb 1;118(2):317-328. doi: 10.14309/ajg.0000000000002047. Epub 2022 Sep 30. Am J Gastroenterol. 2023. PMID: 36191274
Indications and safety of newer IBD treatments in the older patient.
Clement B, De Felice K, Afzali A. Clement B, et al. Among authors: afzali a. Curr Gastroenterol Rep. 2023 Jul;25(7):160-168. doi: 10.1007/s11894-023-00874-9. Epub 2023 May 25. Curr Gastroenterol Rep. 2023. PMID: 37227615 Free PMC article. Review.
Women's Health and Ulcerative Colitis.
Clark-Snustad K, Butnariu M, Afzali A. Clark-Snustad K, et al. Among authors: afzali a. Gastroenterol Clin North Am. 2020 Dec;49(4):769-789. doi: 10.1016/j.gtc.2020.07.004. Epub 2020 Sep 19. Gastroenterol Clin North Am. 2020. PMID: 33121695 Review.
Reply.
Afzali A, Sinanan MN, Lee SD. Afzali A, et al. Inflamm Bowel Dis. 2017 Jan;23(1):E3. doi: 10.1097/MIB.0000000000000985. Inflamm Bowel Dis. 2017. PMID: 28002133 No abstract available.
Efficacy and safety of 48 weeks of guselkumab for patients with Crohn's disease: maintenance results from the phase 2, randomised, double-blind GALAXI-1 trial.
Danese S, Panaccione R, Feagan BG, Afzali A, Rubin DT, Sands BE, Reinisch W, Panés J, Sahoo A, Terry NA, Chan D, Han C, Frustaci ME, Yang Z, Sandborn WJ, Hisamatsu T, Andrews JM, D'Haens GR; GALAXI-1 Study Group. Danese S, et al. Among authors: afzali a. Lancet Gastroenterol Hepatol. 2024 Feb;9(2):133-146. doi: 10.1016/S2468-1253(23)00318-7. Epub 2023 Dec 14. Lancet Gastroenterol Hepatol. 2024. PMID: 38104569 Clinical Trial.
Social Media-The Next Glass Ceiling?
Balzora S, Afzali A, Bewtra M. Balzora S, et al. Among authors: afzali a. Gastroenterology. 2021 Jul;161(1):373-374. doi: 10.1053/j.gastro.2021.02.044. Epub 2021 Feb 24. Gastroenterology. 2021. PMID: 33639154 No abstract available.
50 results